CENTRAL LABORATORIES FEATURED ARTICLES
CENTRAL LABORATORIES WHITE PAPERS & ARTICLES
-
![predictive medical analytics, digital AI interface, patient data, DNA insights-GettyImages-2262212753]( "Interpreting Early Inflammation Signals: What Early Human Data Tells Us")
Interpreting Early Inflammation Signals: What Early Human Data Tells UsEarly inflammatory signals can mislead without context. Benchmarked human challenge models reveal true biological activity, guiding decisions on mechanism, dosing, and clinical development.
-
![GettyImages-2234439798-AI-Medicine-Trials-Drug-Development]( "Responsible AI In Clinical Trials Starts With How It Is Designed")
Responsible AI In Clinical Trials Starts With How It Is DesignedExplore how trials can responsibly use AI to move faster while keeping human judgment, data protections, and auditability intact.
-
![peptides-preclinical-develop-GettyImages-2264393871]( "Why Benchmarking Inflammatory Models Matters: What Early Human Data Tells Us")
Why Benchmarking Inflammatory Models Matters: What Early Human Data Tells UsBenchmarking immune challenge models clarifies early pharmacodynamic signals, helping teams distinguish true target engagement from variability, prioritize endpoints, and make confident decisions.
-
![assay plate, immunology, serology-GettyImages-1425761734]( "Expression Of Key Immunology Drug Targets In Human Inflammatory Challenge Models")
Expression Of Key Immunology Drug Targets In Human Inflammatory Challenge ModelsHuman challenge models reveal immune pathway behavior in controlled settings, linking early research to outcomes and helping confirm target engagement, refine dosing, and reduce development uncertainty.
-
![predictive medical analytics, digital AI interface, patient data, DNA insights-GettyImages-2262212753]( "Data Quality And Monitoring In Clinical Trials: Reducing Errors And Ensuring Compliance")
Data Quality And Monitoring In Clinical Trials: Reducing Errors And Ensuring ComplianceClear data ownership and tailored reporting tools reduce errors and manual reconciliation, keeping trial data accurate and audit-ready.
CENTRAL LABORATORIES APPLICATIONS & STUDIES
-
Mid-Study Randomization: Ensuring Data Integrity In Oncology Trials7/5/2026
Miscommunication between supply chain vendors risks costly delays. Discover how unifying physical and digital operations catches issues before they disrupt a trial.
-
Reserving Data Integrity With Retrospective Manual Entry7/5/2026
A look at implementing randomization mid-trial by reconstructing subject and inventory records without disrupting sites or compromising data integrity.
-
Study Experience: Pancreatic Cancer6/17/2026
Discover how access to robust historical datasets is helping sponsors make smarter decisions earlier and increase the likelihood of clinical and regulatory success
-
A Mission To Expand Recruitment Territory6/11/2026
Learn how a proactive feasibility approach helps sponsors strengthen enrollment forecasting, mitigate risk, and implement timely interventions that improve study execution and clinical development.
-
Accelerating Enrollment And Upholding Quality In Complex Oncology Trials5/5/2026
Real-world oncology trials reveal how fast physician engagement, hands-on biomarker management, and adaptive enrollment shorten timelines, reach first-patient milestones, and preserve data quality.
CENTRAL LABORATORIES PRODUCTS & SERVICES
The Revvity Signals Software Risk-Based Monitoring Solution is the most effective way to leverage data-driven insights to optimize site performance while improving patient safety.
Developing a therapy for a rare or ultra-rare disease is life-changing work with unique challenges. Examine how natural history data is being used to inform the clinical development process.
What can 22,000 people with an AI-mindset accomplish?
Speed without shortcuts
AI in clinical development at Parexel enables our teams to surface predictive insights at every stage, reducing protocol risk, study delays, and costly trial amendments.
Parexel's approach to AI in clinical development is built on the Precision Pathway, a strategic operating model that embeds AI across the full trial lifecycle. AI empowers our teams at critical decision points to:
- Simplify complex tasks to accelerate timelines: AI capabilities are delivering up to 50% cycle time reductions in IND submission generation.
- Apply insights with agility to enable better decision-making
- Enhance data handling to drive first-time quality through content generation and workflow automation
ProPharma is committed to ensuring clients achieve optimal results. As your Benchling partner, our team of R&D Technology experts will ensure you obtain the most value from your Benchling software investment.
Change how you compete by getting the clinical data services and support you need. Medrio is here to help clinical trial sponsors and CROs build internal expertise and support any clinical trial data management needs.
It’s about time.
Modern ePRO/eCOA.
Solved.
Don’t wait a lifetime to launch a study that’s just “good enough”. Build and design a data collection experience that patients and sites will love to use.
Bioforum’s Clinical Data Management team is fully committed to providing high-quality and reliable services using the industry’s leading technology designed for quality data capture.
Enable secure, flexible data exchange with open REST integrations—streamlining workflows, reducing manual effort, and supporting modern, audit‑ready clinical operations.
CENTRAL LABORATORIES SOLUTIONS
- Intelligent Trials - Diversity
- Intelligent Trials: Design and Execute Faster Trials with AI-Powered Insights
- Generate Regulatory-Grade, RWE With Speed And Efficiency
- Modernizing Clinical Research Through Digital Transformation
- Data Monitoring Committee (DMC) Services
- Starting A New Study? This One's For You
- Powering Smarter Treatments And Healthier People
- Feasibility As A Service From Consulting & Analytics
- Unlock Your Clinical Imaging Data Potential
- Unified Clinical Trial Platform Delivering Patient, Data, And Study Experiences
VIDEOS
NEWS
- Signant Health Acquires Ametris To Create An End-To-End eCOA And Wearables Platform
- Avance Clinical Announces Asia Pacific And Mainland China Expansion Ahead Of BIO International Convention 2026
- The Ottawa Hospital's Biotherapeutics Manufacturing Centre (BMC) Makes Breakthroughs Break Through As Boreal Biomanufacturing
- Suvoda Patient App Earns "Best Patient Relationship Management Solution" In 2026 MedTech Breakthrough Awards Program
- Quotient Sciences Advances AI-Designed Drug Product Into Clinical Development
- Paradigm Health Announces Collaboration With The FDA To Transform Regulatory Review Of Clinical Trial Data
- Inside Information: Nanoform Signs First Exclusivity Agreement For Ultra-High Concentration Subcutaneous Delivery
- Suvoda Announces Agentic RTSM, Enabling The Reduction Of Clinical Trial Startup Timelines By Up To 80%
- Signant Health Enters Definitive Agreement To Acquire Ametris
- Crucial Data Solutions Expands TrialKit AI With Study Simulation And Validation Capabilities
- AI HealthTech Pioneer Biorce Opens U.S. Offices In Austin To Accelerate Global Expansion
- Signant Health Appoints Specialist Physician And Clinical Research Expert Dr. Graham C. Ellis As Clinical Vice President To Strengthen Metabolic Disease And Diabetes Trial Capabilities
- Suvoda Advances Clinical Trial Financial Planning With Support For Complex Multi-Payee Budgets
- Suvoda Named "Most Innovative Clinical Trial Technology Firm Of 2026"
- Avance Clinical Appoints Liahna Toy To Lead Global Early Phase Center Of Excellence
- Avance Clinical Strengthens Global Oncology Offering With Acquisition Of U.S-Based LumaBridge
- Health Equity Research Goes Global—Without Waiting For Perfect Data
- International Study Confirms Universal Digital Health Framework
- ISPOR Announces New Executive Director
- Quotient Sciences Extends Commercial Manufacturing Partnership For Ultra-Rare Disease Treatment
- Sygnature Discovery Unveils Strategic Rebrand To Cement Status As A Global Drug Discovery Partner
- Suvoda Sets New Standard For Streamlined Patient And Site Experience In Clinical Trials
- Suvoda IRT Named A Leader In Everest Group's RTSM PEAK Matrix®
- Altasciences Announces Chris Perkin Appointed To Board Of Directors; Marie-Hélène Raigneau Appointed Chief Executive Officer
- AI Agent Enhances Principal Investigator Oversight Of eCOA Data
- Medable Debuts AI Agent for Automating Trial Master File (TMF) Processes
- Univo IRB And The Patient View Announce Partnership
- Avance Clinical Launches Diversity In STEM Scholarships Across Australia And North America
- Lindus Health And Quotient Sciences Partner To Accelerate Drug Development From First-In-Human To Pivotal Trials
- Integrating Lyft Healthcare As An Affordable On-Demand Transportation Provider For Clinical Trial Participants: A Move Towards Enhanced Patient Experience